Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries RayzeBio, Inc. - Common Stock (NQ: RYZB ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 62.49 (10) Ask (Size) 62.54 (3) Prev. Close 62.49 Today's Range N/A - N/A 52wk Range 20.65 - 62.51 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments March 19, 2024 AstraZeneca to acquire Fusion Pharmaceuticals for $21.00 per share cash plus $3.00 per share CVR upon regulatory milestone achievement, marking a significant $2.4 billion deal. Enhancing cancer... Via Benzinga Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer February 23, 2024 From Bristol Myers Squibb Via Business Wire Performance More News Read More BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay Therapeutics, Inc. (Nasdaq – CBAY), Masonite International Corporation (NYSE – DOOR), ZeroFox Holdings, Inc. (Nasdaq – ZFOX), RayzeBio, Inc. (Nasdaq – RYZB) February 12, 2024 From Brodsky & Smith LLC Via GlobeNewswire Health Care Company Bristol-Myers Squibb Announces Merger With RayzeBio December 26, 2023 Via Benzinga Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period February 12, 2024 From Bristol Myers Squibb Via Business Wire Pancreatic Cancer Treatments Poised for Major Advances in 2024 February 07, 2024 Via FinancialNewsMedia The Best-Performing U.S. IPOs Of 2023 February 04, 2024 Via Talk Markets IPO watch 2024: Which new stocks will hit the market? January 08, 2024 Via MarketBeat Topics Initial Public Offering Exposures Securities Market Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Via Investor's Business Daily Cramer Says This 'Inexpensive' Stock Is 'Doing Some Great Things With Aerospace' January 05, 2024 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) January 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire RAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB December 31, 2023 From Kahn Swick & Foti, LLC Via Business Wire Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals December 29, 2023 Via MarketBeat Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review December 29, 2023 Via Investor's Business Daily Topics Stocks Exposures US Equities Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 December 29, 2023 Via Benzinga Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned December 27, 2023 Via Benzinga Investor Sentiment Improves; Dow Jumps Over 150 Points December 27, 2023 Via Benzinga Topics Stocks Exposures US Equities BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX) December 26, 2023 From Brodsky & Smith LLC Via GlobeNewswire Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher December 26, 2023 Via Benzinga Topics Stocks Exposures US Equities Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 26, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 26, 2023 Via Benzinga Stocks Extend Gains As Oil Prices Rise December 26, 2023 Via Talk Markets Topics Stocks Exposures US Equities Bristol Myers' $4.1 Billion Deal For RayzeBio Sends RYZB Stock Soaring 100% December 26, 2023 Via Investor's Business Daily Why Is RayzeBio (RYZB) Stock Up 100% Today? December 26, 2023 Via InvestorPlace RYZB Stock Alert: Halper Sadeh LLC Is Investigating RayzeBio, Inc. December 26, 2023 From Halper Sadeh LLC Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
